의료진 상세정보 보기 로그인

눈문/저서

  1. [2018] Intronic variant of EGFR is associated with GBAS expression and survival outcome of early-stage non-small cell lung cancer. (Thorac Cancer)
  2. [2018] Regulatory variants in cancer-related pathway genes predict survival of patients with surgically resected non-small cell lung cancer (GENE)
  3. [2017] Association between polymorphisms in microRNA target sites and survival in early-stage non-small cell lung cancer (Thoracic Cancer)
  4. [2017] Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer (ANNALS OF SURGICAL ONCOLOGY)
  5. [2017] Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer (ONCOTARGET)
  6. [2017] Development of a prognosis-prediction model incorporating genetic polymorphism with pathologic stage in stage I non-small cell lung cancer: A multicenter study (THORACIC CANCER)
  7. [2017] Effects of polymorphism identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer (CANCER GENETICS)
  8. [2017] Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer. (Clin Lung Cancer)
  9. [2017] Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer (GENE)
  10. [2016] The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology. (JOURNAL OF KOREAN MEDICAL SCIENCE)
  11. [2016] Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer (SCIENTIFIC REPORTS)
  12. [2016] Polymorphisms in cancer-related pathway genes and lung cancer. (EUROPEAN RESPIRATORY JOURNAL)
  13. [2016] PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy (SCIENTIFIC REPORTS)
  14. [2016] Genetic Variants in the Wnt Signaling Pathway Are Not Associated with Survival Outcome of Non-Small Cell Lung Cancer in a Korean Population (JOURNAL OF KOREAN MEDICAL SCIENCE)
  15. [2016] A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer (ONCOTARGET)
  16. [2016] The pri-let-7a-2 rs1143770C>T is associated with prognosis of surgically resected non-small cell lung cancer. (Gene)
  17. [2016] Reply to the letter to the editor KRT81 miR-SNP rs3660 is associated with risk and survival of NSCLC by Robles et al. (ANNALS OF ONCOLOGY)
  18. [2015] A Panel of Genetic Polymorphism for the Prediction of Prognosis in Patients with Early Stage Non-Small Cell Lung Cancer after Surgical Resection (PLOS ONE)
  19. [2015] TERT polymorphism rs2853669 influences on lung cancer risk in the Korean population (J Korean Med Sci)
  20. [2015] MicroRNA-146a inhibits epithelial mesenchymal transition in non-small cell lung cancer by targeting insulin receptor substrate-2. (Int J Oncol)
  21. [2015] Functional intronic ERCC1 polymorphism from regulomeDB can predict survival in lung cancer after surgery. (Oncotarget)
  22. [2015] Replication of the results of genome-wide and candidate gene association studies on telomere length in a Korean population (KJIM)
  23. [2015] A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer. (Ann Oncol)
  24. [2015] Prognostic value of hepatoma-derived growth factor-related protein 3 (HRP-3) methylation in non-small cell lung cancer (GENES & GENOMICS)
  25. [2015] RACK1 is a candidate gene associated with the prognosis of patients with early stage non-small cell lung cancer (ONCOTARGET)
  26. [2015] The Influence of TP53 Mutations on the Prognosis of Patients With Early Stage Non-Small Cell Lung Cancer May Depend on the Intratumor Heterogeneity of the Mutations (MOLECULAR CARCINOGENESIS)
  27. [2015] Putative functional variants of XRCC1 identified by RegulomeDB were not associated with lung cancer risk in a Korean population (CANCER GENETICS)
  28. [2014] A Functional Polymorphism in CSF1R Gene Is a Novel Susceptibility Marker for Lung Cancer among Never-Smoking Females (JOURNAL OF THORACIC ONCOLOGY)
  29. [2014] Unmethylation of the CHRNB4 gene is an unfavorable prognostic factor in non-small cell lung cancer (Lung Cancer)
  30. [2014] Telomere length of tumor tissues and survival in patients with early stage non-small cell lung cancer (MOLECULAR CARCINOGENESIS)
  31. [2014] A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population (GENE)
  32. [2014] Replication of results of a genome-wide association study on lung cancer survival in a Korean population (CANCER GENETICS)
  33. [2013] Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy (LUNG CANCER)
  34. [2013] RET Fusion Genes in Korean Non-Small Cell Lung Cancer (J Korean Med Sci)
  35. [2013] A miR-146a Polymorphism (rs2910164) Predicts Risk of and Survival from Colorectal Cancer (ANTICANCER RESEARCH)
  36. [2013] A Functional Variant at 19q13.3, rs967591G > A, Is Associated with Shorter Survival of Early-Stage Lung Cancer (CLINICAL CANCER RESEARCH)
  37. [2013] Genetic and epigenetic alterations of the LKB1 gene and their associations with mutations in TP53 and EGFR pathway genes in Korean non-small cell lung cancers (LUNG CANCER)
  38. [2013] Wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation (MOLECULES AND CELLS)
  39. [2013] Association between Genetic Variants in Pre-MicroRNAs and Survival of Early-Stage NSCLC (JOURNAL OF THORACIC ONCOLOGY)
  40. [2013] Focal necrotizing pneumonia is a distinct entity from lung abscess (Respirology)
  41. [2012] A Functional Polymorphism in the CHRNA3 Gene and Risk of Chronic Obstructive Pulmonary Disease in a Korean Population (J Korean Med Sci)
  42. [2012] Association between Lung Cancer Susceptibility Variants Identified by Genome-Wide Association Studies and the Survival of Non-Small Cell Lung Cancer (J Lung Cancer)
  43. [2012] Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer. (Mol Cells)
  44. [2012] A functional polymorphism on chromosome 15q25 associated with survival of early stage non-small cell lung cancer. (J Thorac Oncol)
  45. [2012] The Author Response: EML4-ALK fusion gene in Korean non-small cell lung cancer. (JOURNAL OF KOREAN MEDICAL SCIENCE)
  46. [2012] Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population1 (Respirology)
  47. [2012] Telomerase Activity and the Risk of Lung Cancer (J Korean Med Sci)
  48. [2012] EML4-ALK fusion gene in Korean non-small cell lung cancer (J Korean Med Sci)
  49. [2012] Quantitative promoter hypermethylation analysis of RASSF1A in lung cancer: Comparison with methylation-specific PCR technique and clinical significance (Mol Med Report.)
  50. [2012] Promoter methylation of Wnt antagonist DKK1 gene and prognostic value in Korean patients with non-small cell lung cancers (Cancer Biomarkers)
  51. [2011] Polymorphisms in Apoptosis-Related Genes and TP53 Mutations in Non-Small Cell Lung Cancer (J Korean Med Sci)
  52. [2011] Hypomethylation of the thymosin β10 gene is not associated with its overexpression in non-small cell lung cancer (Mol Cells)
  53. [2011] AKT1 polymorphisms and survival of early stage non-small cell lung cancer (Journal of surgical oncology)
  54. [2011] Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer (LUNG CANCER)
  55. [2011] Personalized therapy in lung cancer: focused on molecular targeted therapy. (J Lung Cancer)
  56. [2011] Promoter Methylation of the RGC32 Gene in Nonsmall Cell Lung Cancer (CANCER)
  57. [2011] Mutation analysis of the FRK gene in non-small cell lung cancers (LUNG CANCER)
  58. [2011] Dual roles of a variable number of tandem repeat polymorphism in the TERT gene in lung cancer (CANCER SCIENCE)
  59. [2010] Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer (CANCER SCIENCE)
  60. [2010] Somatic Mutations in Epidermal Growth Factor Receptor Signaling Pathway Genes in Non-small Cell Lung Cancers (JOURNAL OF THORACIC ONCOLOGY)
  61. [2010] Association of a Common AGO1 Variant With Lung Cancer Risk: A Two-Stage Case-Control Study (MOLECULAR CARCINOGENESIS)
  62. [2010] POLYMORPHISMS IN THE APOPTOSIS-RELATED GENES AND SURVIVAL OF PATIENTS WITH EARLY STAGE NON-SMALL CELL LUNG CANCER (ANNALS OF SURGICAL ONCOLOGY)
  63. [2010] PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers (LUNG CANCER)
  64. [2010] Low-dose persistent organic pollutants increased telomere length in peripheral leukocytes of healthy Koreans (MUTAGENESIS)
  65. [2010] Polymorphisms in the Caspase Genes and the Risk of Lung Cancer (JOURNAL OF THORACIC ONCOLOGY)
  66. [2010] Hypermethylation of growth Arrest DNA-damage-inducible gene 45 in non-small cell lung cancer and its relationship with clinicopathologic features (MOLECULES AND CELLS)
  67. [2010] Polymorphisms in Matrix Metalloproteinase-1,-9 and-12 Genes and the Risk of Chronic Obstructive Pulmonary Disease in a Korean Population (RESPIRATION)
  68. [2010] A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population (LUNG CANCER)
  69. [2010] TP53 Mutations in Korean Patients with Non-small Cell Lung Cancer (J Korean Med Sci)
  70. [2010] Epigenetic inactivation of retinoid X receptor genes in non-small cell lung cancer and the relationship with clinicopathologic features (CANCER GENETICS AND CYTOGENETICS)
  71. [2010] Infrequent hypermethylation of the PTEN gene in Korean non-small-cell lung cancers (CANCER SCI)
  72. [2010] LKB1 mutations are extremely rare in Korean non-small cell lung cancers (Cancer genetics and cytogenetics)
  73. [2009] SERPINE2 Polymorphisms and Chronic Obstructive Pulmonary Disease (JOURNAL OF KOREAN MEDICAL SCIENCE)
  74. [2009] Epigenetic Inactivation of Homeobox A5 Gene in Nonsmall Cell Lung Cancer and Its Relationship With Clinicopathological Features (MOLECULAR CARCINOGENESIS)
  75. [2009] Polymorphisms in the CASPASE Genes and Survival in Patients With Early-Stage Non-Small-Cell Lung Cancer (JOURNAL OF CLINICAL ONCOLOGY)
  76. [2009] MicroRNA Expression Profiles in Korean Non-Small Cell Lung Cancer (결핵 및 호흡기질환)
  77. [2009] Polymorphisms in Telomere Maintenance Genes and Risk of Lung Cancer (CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION)
  78. [2009] Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features (LUNG CANCER)
  79. [2009] Polymorphisms in the Caspase7 gene and the risk of lung cancer (LUNG CANCER)
  80. [2009] Polymorphisms in the FAS and FASL Genes and Survival of Early Stage Non-small Cell Lung Cancer (CLINICAL CANCER RESEARCH)
  81. [2008] Aberrant methylation of ADAMTS1 in non-small cell lung cancer (CANCER GENETICS AND CYTOGENETICS)
  82. [2008] Polymorphisms in the SERPINA1 Gene and the Risk of Chronic Obstructive Pulmonary Disease in a Korean Population (Tuberculosis and Respiratory Diseases)
  83. [2008] Polymorphisms in interleukin-1B and its receptor antagonist genes and the risk of chronic obstructive pulmonary disease in a Korean population: a case-control study (RESPIRATORY MEDICINE)
  84. [2008] SLC11A1 polymorphisms are associated with the risk of chronic obstructive pulmonary disease in a Korean population (BIOCHEMICAL GENETICS)
  85. [2008] Telomere length and the risk of lung cancer (CANCER SCIENCE)
  86. [2008] Polymorphisms in the type IV collagen alpha 3 gene and the risk of COPD (EUROPEAN RESPIRATORY JOURNAL)
  87. [2008] Identification of polymorphisms in the Caspase-3 gene and their association with lung cancer risk (MOLECULAR CARCINOGENESIS)
  88. [2008] Polymorphisms in the survivin gene and the risk of lung cancer (LUNG CANCER)
  89. [2008] Comprehensive assessment of P21 polymorphisms and lung cancer risk (JOURNAL OF HUMAN GENETICS)
  90. [2008] Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients (BRITISH JOURNAL OF HAEMATOLOGY)
  91. [2008] Identification of polymorphisms in the XIAP gene and analysis of association with lung cancer risk in a Korean population (CANCER GENETICS AND CYTOGENETICS)
  92. [2007] Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features (CANCER)
  93. [2007] +61A > G polymorphism in the EGF gene does not increase the risk of lung cancer (Respirology)
  94. [2007] Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study (BMC Cancer)
  95. [2007] Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population (Lung Cancer)
  96. [2007] Investigation of vascular endothelial growth factor gene Polymorphisms and its association with clinicopathologic characteristics in gastric cancer (Oncology)
  97. [2007] EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients (Cancer Genetics & Cytogenetics)
  98. [2007] Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer (Molecular Carcinogenesis)
  99. [2007] No association between dinucleotide repeat polymorphism in intron 1 of the epidermal growth factor receptor gene EGFR and risk of lung cancer (Cancer Genetics & Cytogenetics)
  100. [2006] Caspase 9 promoter polymorphisms and risk of primary lung cancer (HUMAN MOLECULAR GENETICS)
  101. [2005] Genetic susceptibility to lung cancer in Koreans (고신의대 폐암 심포지엄논문집)
  102. [2003] Tailored therapy in lung cancer (제 11차 가톨릭 호흡기 알레르기 연수강좌 논문집)
  103. [2002] 폐암의 유전적감수성 (대한내과학회 호흡기내과 분과전문의 연수교육집)
  104. [2002] Genetic susceptibility to lung cancer in Koreans (Cancer Research and Treatment)
  105. [2001] 폐암의 유전자치료 (결핵 및 호흡기질환)
  106. [2000] 폐암의 유전자치료 (전남북 호흡기 심포지움 논문집)
  107. [1999] 대장암의 유전자치료 (대장함문학회지)
  108. [1998] 폐암의 유전자치료 (계명대학교 의학유전연구소 주최 학술심포지엄)
  109. [1998] 기침의 감별진단 (대한내과학회지)
  110. [1998] 폐암의 현황 (경북대학교 암연구소주최 제2회 폐암 심포지엄)
  111. [1998] 폐암의 항암화학요법 (연세대학교 호흡기심포지엄)
  112. [1998] 기침 (대한내과학회지)
  113. [1997] 비소세포폐암의 치료에 관한 재고찰 (경북대학교 암센타 주최 제 1회 국제 폐암 심포지엄)
  114. [1996] 암의 유전자치료 (영남대학교 약품개발연구소 학술심포지엄)